Allosteric activation of Trx1 by antagonizing nitrative modification at tyrosine 49 confers neuroprotection against ischemic stroke
Redox Biology · 2026-09 · 95 · 104246
DOI: 10.1016/j.redox.2026.104246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2026-09. Verfasst von Meizhu Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China. Hauptthemen laut MEDLINE: Thioredoxins, Tyrosine, Ischemic Stroke, Neuroprotection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Capital Normal University, Capital Medical University.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke remains a leading cause of mortality and chronic disability worldwide, with limited therapeutic options. Tetramethylpyrazine (TMP) is a natural product with well-established clinical efficacy against ischemic stroke, yet its molecular target and mechanism of action remain elusive. By integrating a bifunctional photoaffinity TMP probe with stable isotope labeling by amino acids in cell culture and activity-based protein profiling (SILAC-ABPP), we identified thioredoxin 1 (Trx1) as a direct target of TMP. We demonstrate that TMP binds specifically to tyrosine 49 (Y49) on Trx1, antagonizes its nitrative modification, and functions as an allosteric activator. This binding enhances Trx1's reductase activity, strengthens its interaction with apoptosis signal-regulating kinase 1 (ASK1), and consequently suppresses the ASK1-p38/JNK signaling cascade. Genetic ablation of Trx1 or ASK1, or pharmacological induction of Trx1 nitration, completely abolishes TMP-mediated neuroprotection. Our findings not only decipher the mechanistic basis for TMP's clinical efficacy but also identify Y49 of Trx1 as a druggable allosteric site, unveiling a novel anti-nitrative therapeutic strategy for ischemic stroke and related disorders involving nitrative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China.
- Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, 100191, China. Electronic address: yliu_pu3h@bjmu.edu.cn.
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China. Electronic address: wjkong@ccmu.edu.cn.
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China. Electronic address: guoqiang@ccmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Capital Normal University
- Capital Medical University
- Peking University
- Beijing Municipal Education Commission
Zitieren
APA
Guo, M., Guo, H., Ren, W., Wang, X., Wang, X., Liu, Y., Kong, W., & Guo, Q. (2026). Allosteric activation of Trx1 by antagonizing nitrative modification at tyrosine 49 confers neuroprotection against ischemic stroke. Redox Biology, 95, 104246. https://doi.org/10.1016/j.redox.2026.104246
Vancouver
Guo M, Guo H, Ren W, Wang X, Wang X, Liu Y, et al. Allosteric activation of Trx1 by antagonizing nitrative modification at tyrosine 49 confers neuroprotection against ischemic stroke. Redox Biology. 2026;95:104246. doi:10.1016/j.redox.2026.104246
BibTeX
@article{Guo2026,
author = {Guo, Meizhu and Guo, Huan and Ren, Wenshuo and Wang, Xiaonian and Wang, Xing and Liu, Yang and Kong, Weijun and Guo, Qiang},
title = {Allosteric activation of Trx1 by antagonizing nitrative modification at tyrosine 49 confers neuroprotection against ischemic stroke},
journal = {Redox Biology},
year = {2026},
volume = {95},
pages = {104246},
doi = {10.1016/j.redox.2026.104246}
}
EUVIMED